We studied frequency of TET2, SRSF2, ASXL1 and SETBP1 mutations in 145 patients with CMML using Sanger sequencing, and determined the prognostic factors for OS. This evidence concerns the gene SRSF2 and chronic myelomonocytic leukemia.